Medecins Sans Frontiers and other health and relief groups are calling on the vaccine-maker to abandon three patent applications filed years ago in South Africa, saying they could impede a WHO-backed effort to make messenger RNA shots for low-income countries at a hub in Cape Town.
The patents effectively give Moderna the right to stop anyone from making or selling an mRNA vaccine in South Africa, said
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.